A director at Charoen Pokphand Foods Plc bought 50,000 shares at 24.100THB and the significance rating of the trade was 69/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two ...
CPF reported 3Q24 core profit of Bt6.1b, up 12.3% qoq. 3Q24 results were 7% higher than our expectation, but 9% below consensus estimate. The key drivers of 3Q24 profit were higher share of profits, especially from the China swine business. We expect 4Q24 earnings to decline qoq due to lower ASPs of China swine; however, 4Q24 earnings are expected to remain high at Bt5.5b. Maintain BUY. Target price: Bt31.00.
KEY HIGHLIGHTS Results Amata Corporation (AMATA TB/BUY/Bt23.50/Target: Bt35.00) 3Q24: Net income missed expectations but still skyrocketed yoy and qoq. Bangkok Chain Hospital (BCH TB/BUY/Bt16.10/Target: Bt20.00) 3Q24: Mild growth. Central Pattana (CPN TB/BUY/Bt60.00/Target: Bt84.00) 3Q24: Results in line; well-positioned to close 2024 with a new record high. Central Plaza Hotel (CENTEL TB/SELL/Bt33.00/Target: Bt47.00) 3Q24: Better-than-expect...
GREATER CHINA Sector Automobile: Weekly: PV sales dip wow while PEV market share increases. Maintain MARKET WEIGHT. Top BUYs: Geely, CATL, Fuyao Glass and Desay SV. Results Alibaba Health Information Technology (241 HK/BUY/HK$4.04/Target: HK$5.00): 1HFY25: Results in line; expect strong earnings growth momentum in FY25-26. Geely Auto (175 HK/BUY/HK$13.90/Target: HK$23.00): 3Q24: Core earnings up 81% yoy and 29% qoq, beating estimates. Maintain BUY. Raise target price from HK$21.50 to HK$23.00. J...
KEY HIGHLIGHTS Update Charoen Pokphand Foods (CPF TB/BUY/Bt25.00/Target: Bt31.00) Less exciting qoq earnings momentum. Asian Gems Corporate Highlights Kasikorn Bank (KBANK TB/BUY/Bt157.50/Target: Bt190.00) "3+1" strategy aims for double-digit ROE by 2026.
We expect CPF to report 3Q24 core profit of Bt5,725m, up 5% qoq vs a core loss of Bt3.8b in 3Q23. The key drivers were the better China swine business and domestic swine business. We revised up our 2024-25 profit forecasts to reflect the strong profitability level. We foresee less exciting qoq earnings momentum, but expect a 15- 20% consensus earnings upside. Maintain BUY. Target price: Bt31.00.
GREATER CHINA Sector Consumer Golden Week: Tourism and home appliances the bright spots; refocus on China theme. Internet Government policy rollout to boost consumption and drive valuation repair. Update Hong Kong Exchanges and Clearing (388 HK/HOLD/HK$340.80/Target: HK$355.00) Further valuation re-rating requires more sustainable AD...
GREATER CHINA Sector Automobile Weekly: PV sales down 4.8% yoy, missing estimates. Maintain MARKET WEIGHT. Top BUYs: CATL, Desay SV, and Geely. Top SELL: GAC. INDONESIA Update Bank Central Asia (BBCA IJ/BUY/Rp10,850/Target: Rp12,000) Strong loan growth continues; asset quality remains solid. MALAYSIA Update SD Guthrie (SDG MK/HOLD/RM4.88/Target: RM4.75) Plantatio...
GREATER CHINA Strategy Alpha Picks: September Conviction Calls: We expect an improving operating performance among selected companies in September, and add AIA, COLI, Desay SV, Galaxy Entertainment, Meituan, Ping An and TUL to our BUY list and add Li Auto as a SELL. INDONESIA Strategy Alpha Picks: Trailing The JCI’s Strong Performance In Aug 24: Our picks are ICBP, TOWR, BBNI, BMRI, BBRI, EXCL, CTRA, BBTN, CMRY, SIDO and JSMR. MALAYSIA Strategy Alpha Picks: Adapting To A Bipolar Market: Our Al...
CPF reported core earnings of Bt5.5b for 2Q24, up from a core loss in 2Q23 and a breakeven in 1Q24, driven by strong gross profit margin and a higher share of profit. Looking forward, we are still positive on 2H24 earnings momentum given a recovery in domestic swine prices and the ASF outbreak in China. We also expect an upward revision in consensus earnings forecast. Maintain BUY. Target price: Bt30.00.
KEY HIGHLIGHTS Strategy Uncertainties Arise as Court Removes PM from Office The court’s verdict raises concerns for the equities market and sector regarding policy continuity and economic stimulus, especially commerce. Results Central Plaza Hotel (CENTEL TB/SELL/Bt32.75/Target: Bt46.00) 2Q24: Weaker-than-expected results. CH Karnchang PCL (CK TB/BUY/Bt18.00/Target: Bt26.50) 2Q24: In line with expectations; expect volatility from polit...
GREATER CHINA Results Nexteer (1316 HK/SELL/HK$2.89/Target: HK$1.50) 1H24: Earnings miss estimates on revenue. Maintain SELL. Cut target price from HK$2.20 to HK$1.50. Tencent Holdings (700 HK/BUY/HK$373.80/Target: HK$490.00) 2Q24: Solid margin expansion; reaccelerated online games revenue growth. Update Foxconn Industrial Internet (601138 CH/BUY/Rmb21.38/Target: Rmb30.00) AI business continues to accelerate, GB200 scheduled to ship i...
GREATER CHINA Strategy Alpha Picks: August Conviction Calls: We expect stimulus to be announced in August and add COSCO Shipping Ports, Haier Smart Home, and KE Holdings to our BUY list and add SELL call on WuXi Bio, and XPeng. INDONESIA Strategy Alpha Picks: Underperformance in Jul 24: Our picks are BBNI, BMRI, BBRI, EXCL, CTRA, BBTN, CMRY, SIDO and JSMR. MALAYSIA Strategy Alpha Picks: Raising The M&A And Monetisation Bets: Our Alpha Picks marginally beat the KLCI. Jul 24 picks: Ekovest, Gamu...
GREATER CHINA Economics Economic Activity 2Q24 growth below expectations. Strategy China And Hong Kong Property Sharper property price decline in 1H24 weighing on margins of Chinese developers; upcoming interest rate cut to support value of Hong Kong retail landlords. Update Kingmed Diagnostics (603882 CH/BUY/Rmb38.10/Target: Rmb35.00) 1H24 and 2024 results under pressu...
We expect CPF to report 2Q24 core profit of Bt3,819m, up from a core loss of Bt4,105m in 2Q23 and a significant 1,310% qoq increase from 1Q24 on the back of profitability improvement. We revised up our 2024-25 profit forecasts to reflect the robust turnaround. We foresee 2H24 earnings remaining strong following better swine prices in all key countries. Maintain BUY. Target price: Bt29.00.
KEY HIGHLIGHTS Results Aeon Thana Sinsap (Thailand) (AEONTS TB/HOLD/Bt130.00/Target: Bt148.00) 1QFY24: Results missed substantially; deterioration in asset quality. Downgrade to HOLD. Update Charoen Pokphand Foods (CPF TB/BUY/Bt23.60/Target: Bt29.00) Robust earnings turnaround. PTT Exploration & Production (PTTEP TB/BUY/Bt152.50/Target: Bt200.00) Increases in ASP and sales bolstered net profit for 2Q24.
GREATER CHINA Strategy Alpha Picks: July Conviction Call: Adding ASMPT, Innovent, Poly Property Services, TAL Education and Trip.com to our BUY list; hedging with SELL call on BYD. INDONESIA Strategy Alpha Picks: Outperformance In Jun 24 And 2Q24: Our picks are BMRI, BBRI, EXCL, BSDE, TLKM, ACES, BBTN, CMRY, SIDO and JSMR. MALAYSIA Strategy Alpha Picks: Opting For More Adventurous Choices: Our Alpha Picks beat the KLCI again. Jul 24 picks: BURSA, Ekovest, Gamuda, Lagenda, Mah Sing, MYEG, Pekat...
GREATER CHINA Strategy Alpha Picks: June Conviction Call: Adding KE Holdings and Wharf REIC to our BUY list; hedging with SELL call on BYD. INDONESIA Strategy Alpha Picks: First Month Of Underperformance In 2024: Our picks are EXCL, BSDE, TLKM, ACES, BBTN, CMRY, SIDO and JSMR. MALAYSIA Strategy Alpha Picks: Choices For A “Summer Lull”: Our Alpha Picks trounce the KLCI again. May 24 picks: BAUTO, BURSA, Gamuda, GENM, Lagenda, Mah Sing, MYEG, PMETAL, RGB, and VSI. SINGAPORE Strategy Alpha Picks...
CPF reported an impressive 1Q24 core profit of Bt271m, turning around from a loss and beating our and market expectations. Key drivers were improved profitability and a higher share of profit. For 2024, we expect CPF’s bottom line to remain positive following better domestic and Vietnam performances as well as its business restructuring in 2023. Maintain BUY. Target price: Bt25.10.
KEY HIGHLIGHTS Results Central Pattana (CPN TB/BUY/Bt62.50/Target: Bt83.00) 1Q24: Earnings remained strong; in line with expectations. Charoen Pokphand Foods (CPF TB/BUY/Bt20.60/Target: Bt25.10) 1Q24: Impressive earnings turnaround; positive earnings outlook ahead. COM7 (COM7 TB/HOLD/Bt19.50/Target: Bt23.00) 1Q24: Earnings in line. Pruksa Holding (PSH TB/SELL/Bt11.40/Target: Bt9.20) 1Q2...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.